SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-000672
Filing Date
2020-01-02
Accepted
2020-01-02 16:50:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d851821d424b5.htm 424B5 139829
2 GRAPHIC g851821g02d42.jpg GRAPHIC 15364
3 GRAPHIC g851821snap1.jpg GRAPHIC 10211
  Complete submission text file 0001193125-20-000672.txt   176286
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235642 | Film No.: 20502099
SIC: 2834 Pharmaceutical Preparations